The aim of Boost Invest MedVallée, a program led by Montpellier Métropole, is to support innovative companies in the global health sector, help them structure their fundraising and get connected with the right investors. It is designed for startups selected by a panel of experts for funding needs ranging from €100,000 to €15 million.
Support with significant added value for selected startups
The selected startups benefit from several key levers to maximize their exposure and credibility:
A committee of distinguished experts to select the brightest talents of tomorrow
The program leverages a multidisciplinary committee comprising scientists, researchers, industry experts, investors, and institutional representatives, including:
- Véronique Bellon-Maurel (INRAE, Académie des Sciences)
- Franck Molina (CNRS)
- Alain Thierry (INSERM)
- Marc Ychou (ICM)
- Patrick Caron (CIRAD)
-
It also includes representatives from AD’OCC, IRDI CI, SOFILARO, BPI, Crédit Agricole, Banque Populaire du Sud, Eurobiomed, AquaValley, and others
Territory-wide action to promote global health and ecological transition
Boost Invest MEDVALLÉE is more than just a fundraising initiative; it embodies an ambitious regional dynamic:
- Creating a reference ecosystem at a European level
- Encourage collective intelligence among experts, institutions, and companies
- Promote local know-how internationally
The partners are committed to mobilizing their networks, analyzing proposals, participating in award committees, and supporting startups in their strategic structuring.
Spotlight on the six new 2025 laureates of the Boost Invest MedVallée program
1. Aken Médical
Specializing in targeted internal radiotherapy, Aken Médical develops innovative technology based on radiopharmaceutical nanocapsules capable of precisely targeting cancer cells. The first application is for pancreatic cancer, with plans to address other cancers as well.
“Thanks to Boost Invest MedVallée, we are organizing our fundraising efforts and accelerating our development to move towards large-scale industrialization.”
— Laila Quere, CEO
2. CILOA
Specializing in therapeutic exosomes, CILOA develops a new generation of treatments, notably targeting type 2 diabetes and obesity. Also a laureate of the France 2030 plan, CILOA is preparing clinical trials under GMP conditions.
“The Boost Invest MedVallée investor network will be instrumental in our next round of fundraising.”
— Mealy Kong, CFO
3. Cyberna
This Montpellier-based startup uses epitranscriptomics to detect subclinical cancers from a single drop of blood, long before they are detectable clinically.
“Being selected means that we can benefit from a network of experts and financial backers, which will greatly facilitate our fundraising efforts.”
— Agnès Martinec, CEO
4. Load Stations
Located in Montpellier and Nîmes, Load Stations offers smart, interoperable, white-label charging solutions for electric vehicles, designed for communities and businesses.
“This program represents a real springboard for our development and strategic organization.”
— Virgile Arène, President
5. Neurinnov
A pioneer in selective neurostimulation, Neurinnov enables quadriplegic patients to regain functional use of their hands. This is a major breakthrough in functional medicine.
“Boost Invest MedVallée is a catalyst for accelerating our growth and strengthening our innovation momentum.”
— Nicolas Serandour, President
6. Reeflect
Founded by an engineer whose parents are deaf, Reeflect transforms sounds into light and vibration alerts to help keep people with hearing impairments safe at home and at work.
“Boost Invest MedVallée will enable us to move up to the next level and raise €1 million.”
— Anthony Denux, CEO
With Boost Invest MedVallée, Montpellier Métropole confirms its determination to nurture innovation champions in the global health sector, while building a network of public and private players capable of transforming local ambitions into international success stories.
